Abcellera Biologics Inc (ABCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ABCL | AMGN | VRTX | BMY | GILD |
| Company | Abcellera Biologics Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 2.50 | 316.16 | 483.00 | 55.14 | 89.64 |
| High | 2.75 | 319.18 | 497.00 | 55.80 | 90.26 |
| Low | 2.50 | 313.02 | 474.00 | 54.72 | 89.01 |
| Last | 2.66 | 318.73 | 496.46 | 55.90 | 90.24 |
| Change | -0.23 | +1.82 | +23.66 | +0.45 | +0.40 |
| % Change | -7.96% | +0.57% | +5.00% | +0.81% | +0.45% |
| Volume | 2,191,168 | 443,962 | 649,552 | 2,636,033 | 1,316,625 |
| 20-Day Average Volume | 1,910,039 | 1,669,063 | 1,016,524 | 8,374,987 | 5,018,318 |
| Previous Close | 2.89 | 316.91 | 472.80 | 55.45 | 89.84 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.71 | 319.64 | 478.59 | 53.22 | 87.51 |
| 20-Day Raw Stochastic | 53.92% | 38.62% | 86.77% | 87.52% | 89.76% |
| 20-Day Relative Strength | 49.56% | 46.52% | 58.53% | 63.07% | 69.38% |
| Weighted Alpha | -38.38 | +16.00 | +30.40 | +17.23 | +27.29 |
| Today's Opinion | 56% Sell | 8% Buy | 88% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 24% Sell | 8% Buy | 24% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 88% Sell | 24% Buy | 8% Sell | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.12% since 10/29/24 | +0.57% since 10/29/24 | +4.90% since 10/29/24 | +5.89% since 10/29/24 | +2.23% since 10/29/24 |
| Low | 2.50 on 11/05/24 | 310.63 on 10/30/24 | 463.14 on 11/01/24 | 52.29 on 10/30/24 | 87.48 on 10/30/24 |
| High | 2.90 on 11/04/24 | 323.40 on 10/31/24 | 494.87 on 11/05/24 | 56.20 on 10/31/24 | 90.71 on 11/04/24 |
| 1-Month | |||||
| %Chg | +7.40% since 10/04/24 | -0.58% since 10/04/24 | +8.37% since 10/04/24 | +3.02% since 10/04/24 | +6.44% since 10/04/24 |
| Low | 2.41 on 10/10/24 | 310.63 on 10/30/24 | 447.70 on 10/07/24 | 51.31 on 10/15/24 | 84.17 on 10/11/24 |
| High | 2.92 on 10/21/24 | 329.17 on 10/11/24 | 499.09 on 10/17/24 | 56.20 on 10/31/24 | 90.71 on 11/04/24 |
| 3-Month | |||||
| %Chg | -2.72% since 08/05/24 | -2.28% since 08/05/24 | +3.46% since 08/05/24 | +16.81% since 08/05/24 | +20.33% since 08/05/24 |
| Low | 2.34 on 09/10/24 | 306.59 on 08/07/24 | 447.70 on 10/07/24 | 46.22 on 08/08/24 | 72.43 on 08/12/24 |
| High | 2.92 on 09/18/24 | 339.17 on 09/23/24 | 500.25 on 08/30/24 | 56.20 on 10/31/24 | 90.71 on 11/04/24 |
| 6-Month | |||||
| %Chg | -33.37% since 05/03/24 | +2.09% since 05/03/24 | +23.02% since 05/03/24 | +26.37% since 05/03/24 | +38.99% since 05/03/24 |
| Low | 2.34 on 09/10/24 | 295.30 on 06/13/24 | 394.03 on 05/07/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 4.34 on 05/28/24 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 56.20 on 10/31/24 | 90.71 on 11/04/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 851,585 | 170,284,928 | 122,030,624 | 112,462,416 | 111,850,072 |
| Shares Outstanding, K | 294,666 | 537,329 | 258,102 | 2,028,177 | 1,244,992 |
| Annual Sales | 38,030,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -146,400,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 7,320,000 | 8,503,000,000 | 2,645,600,000 | 11,892,000,000 | 6,954,000,000 |
| Last Quarter Net Income | -36,930,000 | 2,830,000,000 | -3,593,600,000 | 1,211,000,000 | 1,614,000,000 |
| 60-Month Beta | 0.35 | 0.60 | 0.39 | 0.44 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.13 on 08/06/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.01 on 08/08/24 |
| Latest Earnings Date | 11/04/24 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 09/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.61 | 0.00 | 46.43 | 19.04 |